Kerry Solomon, MD
Ophthalmology · Mt Pleasant, SCNPI 1881608024
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,640,895 of the $1,740,501 with a category attached, or 94.3%. 17 manufacturers reported payments, led by Carl Zeiss Meditec Digital Innovations LLC at 55.4% of the total. Reporting peaked in 2019 at $372,117 and has fallen 68.9% since, to $115,756 in 2025. Among ophthalmology clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 492 payments — averaging $3537.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec Digital Innovations LLC$964K
- Alcon$422K
- Carl Zeiss Meditec, Inc.$131K
- Alcon Research LLC$100K
- Glaukos Corporation$59K
- Rxsight Inc$44K
- plus $22K from 11 others
Across 993 payments — averaging $2912.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$1.3M
- Johnson & Johnson Surgical Vision, Inc.$1.2M
- Rxsight Inc$439K
- Oyster Point Pharma, Inc.$3K
Across 4 payments — averaging $1180.44 each. An ownership or investment interest held by the physician or an immediate family member.
- Lensar, Inc.$5K
- Rxsight Inc$0
What the payments were for
- Consulting fees$1,640,89594%
- Speaking & faculty fees$25,5011%
- Travel & lodging$43,0082%
- Food & beverage$17,0581%
- Education$2,2500%
- Gifts$11,6831%
- Entertainment$1060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec Digital Innovations LLC | 25 | $963,783 |
| Alcon | 223 | $421,566 |
| Carl Zeiss Meditec, Inc. | 53 | $130,691 |
| Alcon Research LLC | 60 | $99,893 |
| Glaukos Corporation | 29 | $58,861 |
| Rxsight Inc | 20 | $43,651 |
| Johnson & Johnson Surgical Vision, Inc. | 16 | $14,890 |
| Lensar, Inc. | 5 | $3,572 |
| Carl Zeiss Meditec USA, Inc. | 24 | $1,649 |
| AbbVie | 1 | $363 |
| Biotissue Holdings Inc. | 5 | $358 |
| Ocular Therapeutix, Inc. | 19 | $354 |
| Harrow Eye, LLC | 4 | $323 |
| NEW World Medical,inc. | 2 | $271 |
| Omeros Corporation | 2 | $134 |
| Johnson & Johnson Vision Care, Inc. | 1 | $85 |
| Rayner Intraocular Lenses Limited | 3 | $57 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERACITY SURGICAL$979,433
- Clareon$181,607
- Centurion$166,407
- Wavelight Refractive Suite$136,043
- AcrySof IQ PanOptix$92,297
- IOLMaster 700$61,099
- AcrySof IQ VIVITY$57,900
- CIRRUS HD-OCT$55,500
- AcrySof IQ VIVITY IOL$47,487
- RXSIGHT CONTACT LENS$41,192
- RXSIGHT INJECTOR CARTRIDGE$41,192
- RXSIGHT INJECTOR HANDPIECE$41,192
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$41,192
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$40,956
- iStent inject Trabecular Micro-Bypass Stent System$40,106
- iStent Trabecular Micro-Bypass Stent System$40,000
- VisuMax$38,625
- Cataract Suite$36,938
- OPMI Lumera 700$32,626
- AcrySof$28,280
How this compares
$1,740,501 in reported general payments places this provider in the 95th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Loteprednol Etabonate | 11 | $2,437 |
| Prednisolone Acetate | 39 | $1,970 |
| Ketorolac Tromethamine | 30 | $1,095 |
| Ofloxacin | 38 | $555 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Mt Pleasant
- George WaringMt Pleasant$645K
- Erik HappMt Pleasant$124K
- William ClarkWest Columbia$768K
- Karolinne RochaCharleston$552K
- Joseph BishopHilton Head Island$136K
- Matthew ClaryColumbia$119K
- Kunal KanitkarLexington$83K
- Carl SloanMyrtle Beach$78K
- David VromanLadson$61K
- Drew DicksonCharleston$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.